Underbjerg L, Sikjaer T, Mosekilde L et al (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30:1738–1744

Article  CAS  PubMed  Google Scholar 

Nakamura Y, Matsumoto T, Tamakoshi A et al (2000) Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 10:29–33

Article  CAS  PubMed  Google Scholar 

Halabe A, Arie R, Mimran D et al (1994) Hypoparathyroidism–a long-term follow-up experience with 1 alpha-vitamin D3 therapy. Clin Endocrinol (Oxf) 40:303–307

Article  CAS  PubMed  Google Scholar 

Cooper MS, Gittoes NJ (2008) Diagnosis and management of hypocalcaemia. BMJ 336:1298–1302

Article  PubMed  PubMed Central  Google Scholar 

Denko JD, Kaelbling R (1962) The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand Suppl 38:1–70

CAS  PubMed  Google Scholar 

Arlt W, Fremerey C, Callies F et al (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215–222

Article  CAS  PubMed  Google Scholar 

Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58:14–20

Article  PubMed  Google Scholar 

Palermo A, Santonati A, Tabacco G et al (2018) PTH (1–34) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 103:271–280

Article  PubMed  Google Scholar 

Cusano NE, Rubin MR, McMahon DJ et al (2013) The effect of PTH (1–84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab 98:2356–2361

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cusano NE, Rubin MR, McMahon DJ et al (2014) PTH (1–84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab 99:3694–3699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santonati A, Palermo A, Maddaloni E et al (2015) PTH (1–34) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 100:3590–3597

Article  CAS  PubMed  Google Scholar 

Tabacco G, Tay YD, Cusano NE et al (2019) Quality of Life in hypoparathyroidism improves with rhPTH (1–84) throughout 8 Years of therapy. J Clin Endocrinol Metab 104:2748–2756

Article  PubMed  PubMed Central  Google Scholar 

Sikjaer T, Rolighed L, Hess A et al (2014) Effects of PTH(1–84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int 25:1717–1726

Article  CAS  PubMed  Google Scholar 

Roszko KL, Hu TY, Guthrie LC et al (2022) PTH 1–34 replacement therapy has minimal effect on quality of life in patients with hypoparathyroidism. J Bone Miner Res 37:68–77

Article  CAS  PubMed  Google Scholar 

Gittoes N, Rejnmark L, Ing SW et al (2021) The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord 21:232

Article  PubMed  PubMed Central  Google Scholar 

Kumanishi T, Washiyama K, Saito T et al (1986) Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies. Acta Neuropathol 71:190–196

Article  CAS  PubMed  Google Scholar 

Jorgensen CU, Homoe P, Dahl M et al (2021) Postoperative chronic hypoparathyroidism and quality of life after total thyroidectomy. JBMR Plus 5:e10479

Article  PubMed  PubMed Central  Google Scholar 

Sikjaer T, Moser E, Rolighed L et al (2016) Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J Bone Miner Res 31:1440–1448

Article  PubMed  Google Scholar 

Astor MC, Lovas K, Debowska A et al (2016) Epidemiology and health-related quality of life in hypoparathyroidism in norway. J Clin Endocrinol Metab 101:3045–3053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Underbjerg L, Sikjaer T, Rejnmark L (2018) Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism. Clin Endocrinol (Oxf) 88:838–847

Article  CAS  PubMed  Google Scholar 

Aggarwal S, Kailash S, Sagar R et al (2013) Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol 168:895–903

Article  CAS  PubMed  Google Scholar 

Sardella A, Bellone F, Morabito N et al (2021) The association between hypoparathyroidism and cognitive impairment: a systematic review. J Endocrinol Invest 44:905–919

Article  CAS  PubMed  Google Scholar 

Saponaro F, Alfi G, Cetani F et al (2022) Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 45:1909–1918

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonavolontà V, Cianferotti L, Iolascon G et al (2022) Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations. J Endocrinol Invest 45:1289–1295

Article  PubMed  Google Scholar 

Balabanov S, Tollner U, Richter HP et al (1984) Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol (Copenh) 106:227–233

CAS  PubMed  Google Scholar 

Usdin TB, Gruber C, Bonner TI (1995) Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270:15455–15458

Article  CAS  PubMed  Google Scholar 

Bago AG, Dimitrov E, Saunders R et al (2009) Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162:128–147

Article  CAS  PubMed  Google Scholar 

Vokes TJ, Mannstadt M, Levine MA et al (2018) Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J Clin Endocrinol Metab 103:722–731

Article  PubMed  Google Scholar 

Chomsky-Higgins KH, Rochefort HM, Seib CD et al (2018) Recombinant parathyroid hormone versus usual care: do the outcomes justify the cost? World J Surg 42:431–436

Article  PubMed  Google Scholar